nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—psoriatic arthritis	0.618	1	CbGaD
Chloroquine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0315	0.118	CbGbCtD
Chloroquine—CYP1A1—Dexamethasone—psoriatic arthritis	0.0305	0.114	CbGbCtD
Chloroquine—ABCB1—Betamethasone—psoriatic arthritis	0.0205	0.0768	CbGbCtD
Chloroquine—ABCB1—Prednisolone—psoriatic arthritis	0.0202	0.0758	CbGbCtD
Chloroquine—ABCB1—Prednisone—psoriatic arthritis	0.0191	0.0716	CbGbCtD
Chloroquine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0189	0.0708	CbGbCtD
Chloroquine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0183	0.0687	CbGbCtD
Chloroquine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0176	0.066	CbGbCtD
Chloroquine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0143	0.0537	CbGbCtD
Chloroquine—CYP3A4—Betamethasone—psoriatic arthritis	0.0123	0.046	CbGbCtD
Chloroquine—CYP3A4—Prednisolone—psoriatic arthritis	0.0121	0.0454	CbGbCtD
Chloroquine—ABCB1—Dexamethasone—psoriatic arthritis	0.0119	0.0447	CbGbCtD
Chloroquine—CYP3A4—Prednisone—psoriatic arthritis	0.0114	0.0429	CbGbCtD
Chloroquine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0112	0.0421	CbGbCtD
Chloroquine—ABCB1—Methotrexate—psoriatic arthritis	0.00957	0.0359	CbGbCtD
Chloroquine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00713	0.0268	CbGbCtD
Chloroquine—Personality change—Prednisolone—psoriatic arthritis	0.00324	0.0395	CcSEcCtD
Chloroquine—Personality change—Triamcinolone—psoriatic arthritis	0.00298	0.0363	CcSEcCtD
Chloroquine—Personality change—Methylprednisolone—psoriatic arthritis	0.00297	0.0362	CcSEcCtD
Chloroquine—Personality change—Dexamethasone—psoriatic arthritis	0.0027	0.0329	CcSEcCtD
Chloroquine—Personality change—Betamethasone—psoriatic arthritis	0.0027	0.0329	CcSEcCtD
Chloroquine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriatic arthritis	0.00251	0.0745	CbGpPWpGaD
Chloroquine—Personality change—Prednisone—psoriatic arthritis	0.00236	0.0287	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.00192	0.0571	CbGpPWpGaD
Chloroquine—Atrophy—Prednisolone—psoriatic arthritis	0.00191	0.0232	CcSEcCtD
Chloroquine—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00183	0.0223	CcSEcCtD
Chloroquine—Atrophy—Triamcinolone—psoriatic arthritis	0.00175	0.0213	CcSEcCtD
Chloroquine—Atrophy—Methylprednisolone—psoriatic arthritis	0.00175	0.0213	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.00163	0.0485	CbGpPWpGaD
Chloroquine—Atrophy—Betamethasone—psoriatic arthritis	0.00159	0.0194	CcSEcCtD
Chloroquine—Atrophy—Dexamethasone—psoriatic arthritis	0.00159	0.0194	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL15—psoriatic arthritis	0.00152	0.0451	CbGpPWpGaD
Chloroquine—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.0015	0.0183	CcSEcCtD
Chloroquine—Atrophy—Prednisone—psoriatic arthritis	0.00139	0.0169	CcSEcCtD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.00138	0.0408	CbGpPWpGaD
Chloroquine—Eosinophilia—Auranofin—psoriatic arthritis	0.00121	0.0147	CcSEcCtD
Chloroquine—Pancytopenia—Auranofin—psoriatic arthritis	0.00116	0.0141	CcSEcCtD
Chloroquine—Neutropenia—Auranofin—psoriatic arthritis	0.00114	0.0139	CcSEcCtD
Chloroquine—Reaction gastrointestinal—Methotrexate—psoriatic arthritis	0.00113	0.0138	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL13—psoriatic arthritis	0.00107	0.0318	CbGpPWpGaD
Chloroquine—Agranulocytosis—Auranofin—psoriatic arthritis	0.00102	0.0124	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL17A—psoriatic arthritis	0.00101	0.0301	CbGpPWpGaD
Chloroquine—TNF—IL27-mediated signaling events—IL12B—psoriatic arthritis	0.000943	0.028	CbGpPWpGaD
Chloroquine—Visual impairment—Auranofin—psoriatic arthritis	0.000943	0.0115	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL12B—psoriatic arthritis	0.000915	0.0272	CbGpPWpGaD
Chloroquine—TNF—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.0009	0.0267	CbGpPWpGaD
Chloroquine—Myopathy—Prednisolone—psoriatic arthritis	0.000886	0.0108	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000868	0.0258	CbGpPWpGaD
Chloroquine—Alopecia—Auranofin—psoriatic arthritis	0.000865	0.0105	CcSEcCtD
Chloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000861	0.0255	CbGpPWpGaD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000845	0.0251	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000815	0.0242	CbGpPWpGaD
Chloroquine—Myopathy—Triamcinolone—psoriatic arthritis	0.000815	0.00992	CcSEcCtD
Chloroquine—Myopathy—Methylprednisolone—psoriatic arthritis	0.000813	0.0099	CcSEcCtD
Chloroquine—Angioedema—Auranofin—psoriatic arthritis	0.000778	0.00948	CcSEcCtD
Chloroquine—TNF—Apoptosis—LTA—psoriatic arthritis	0.000776	0.023	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.000765	0.0227	CbGpPWpGaD
Chloroquine—TNF—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.000745	0.0221	CbGpPWpGaD
Chloroquine—Myopathy—Dexamethasone—psoriatic arthritis	0.000739	0.009	CcSEcCtD
Chloroquine—Myopathy—Betamethasone—psoriatic arthritis	0.000739	0.009	CcSEcCtD
Chloroquine—TNF—TNF receptor signaling pathway —TNFRSF1B—psoriatic arthritis	0.000721	0.0214	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.000711	0.0211	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.000681	0.00829	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000678	0.0201	CbGpPWpGaD
Chloroquine—Anorexia—Auranofin—psoriatic arthritis	0.000663	0.00807	CcSEcCtD
Chloroquine—Myopathy—Prednisone—psoriatic arthritis	0.000644	0.00784	CcSEcCtD
Chloroquine—Eruption—Methotrexate—psoriatic arthritis	0.000613	0.00747	CcSEcCtD
Chloroquine—Decreased appetite—Auranofin—psoriatic arthritis	0.000604	0.00736	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000598	0.0177	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000579	0.0172	CbGpPWpGaD
Chloroquine—Urticaria—Auranofin—psoriatic arthritis	0.000552	0.00673	CcSEcCtD
Chloroquine—Abdominal pain—Auranofin—psoriatic arthritis	0.00055	0.00669	CcSEcCtD
Chloroquine—Skin exfoliation—Triamcinolone—psoriatic arthritis	0.000546	0.00664	CcSEcCtD
Chloroquine—Skin exfoliation—Methylprednisolone—psoriatic arthritis	0.000544	0.00663	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—HLA-DRB1—psoriatic arthritis	0.000539	0.016	CbGpPWpGaD
Chloroquine—Delirium—Prednisone—psoriatic arthritis	0.000525	0.00639	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—MEFV—psoriatic arthritis	0.000499	0.0148	CbGpPWpGaD
Chloroquine—Skin exfoliation—Betamethasone—psoriatic arthritis	0.000495	0.00603	CcSEcCtD
Chloroquine—Skin exfoliation—Dexamethasone—psoriatic arthritis	0.000495	0.00603	CcSEcCtD
Chloroquine—Pruritus—Auranofin—psoriatic arthritis	0.000492	0.00599	CcSEcCtD
Chloroquine—Visual disturbance—Prednisolone—psoriatic arthritis	0.000476	0.0058	CcSEcCtD
Chloroquine—Diarrhoea—Auranofin—psoriatic arthritis	0.000476	0.00579	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.000466	0.00567	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—HLA-C—psoriatic arthritis	0.000456	0.0135	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL13—psoriatic arthritis	0.000453	0.0135	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TNFRSF1B—psoriatic arthritis	0.000446	0.0132	CbGpPWpGaD
Chloroquine—Vomiting—Auranofin—psoriatic arthritis	0.000442	0.00538	CcSEcCtD
Chloroquine—TNF—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.000439	0.013	CbGpPWpGaD
Chloroquine—Rash—Auranofin—psoriatic arthritis	0.000438	0.00534	CcSEcCtD
Chloroquine—Skin exfoliation—Prednisone—psoriatic arthritis	0.000431	0.00525	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.000429	0.00522	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.000428	0.00521	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL17A—psoriatic arthritis	0.000417	0.0124	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.000414	0.0123	CbGpPWpGaD
Chloroquine—Nausea—Auranofin—psoriatic arthritis	0.000413	0.00503	CcSEcCtD
Chloroquine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.000404	0.00492	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.000399	0.0118	CbGpPWpGaD
Chloroquine—Visual disturbance—Betamethasone—psoriatic arthritis	0.000397	0.00484	CcSEcCtD
Chloroquine—Visual disturbance—Dexamethasone—psoriatic arthritis	0.000397	0.00484	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.000389	0.00473	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.000389	0.00473	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL12B—psoriatic arthritis	0.000388	0.0115	CbGpPWpGaD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000383	0.0114	CbGpPWpGaD
Chloroquine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.000368	0.00448	CcSEcCtD
Chloroquine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.000368	0.00448	CcSEcCtD
Chloroquine—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00036	0.00439	CcSEcCtD
Chloroquine—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000354	0.00431	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.000338	0.01	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000328	0.00974	CbGpPWpGaD
Chloroquine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00032	0.0039	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000316	0.00938	CbGpPWpGaD
Chloroquine—Photosensitivity—Methotrexate—psoriatic arthritis	0.000312	0.0038	CcSEcCtD
Chloroquine—Visual impairment—Prednisolone—psoriatic arthritis	0.000301	0.00366	CcSEcCtD
Chloroquine—TLR9—Immune System—MEFV—psoriatic arthritis	0.00029	0.00862	CbGpPWpGaD
Chloroquine—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00029	0.00353	CcSEcCtD
Chloroquine—Visual disturbance—Methotrexate—psoriatic arthritis	0.000289	0.00352	CcSEcCtD
Chloroquine—Hallucination—Methylprednisolone—psoriatic arthritis	0.000285	0.00347	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000283	0.00345	CcSEcCtD
Chloroquine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000276	0.00336	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—CRP—psoriatic arthritis	0.000275	0.00817	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—HLA-B—psoriatic arthritis	0.00027	0.00801	CbGpPWpGaD
Chloroquine—Neutropenia—Prednisone—psoriatic arthritis	0.000265	0.00323	CcSEcCtD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000263	0.00781	CbGpPWpGaD
Chloroquine—Hallucination—Betamethasone—psoriatic arthritis	0.000259	0.00315	CcSEcCtD
Chloroquine—Hallucination—Dexamethasone—psoriatic arthritis	0.000259	0.00315	CcSEcCtD
Chloroquine—Vision blurred—Prednisolone—psoriatic arthritis	0.000256	0.00312	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—HLA-C—psoriatic arthritis	0.000255	0.00758	CbGpPWpGaD
Chloroquine—Visual impairment—Betamethasone—psoriatic arthritis	0.000251	0.00306	CcSEcCtD
Chloroquine—Visual impairment—Dexamethasone—psoriatic arthritis	0.000251	0.00306	CcSEcCtD
Chloroquine—Angioedema—Prednisolone—psoriatic arthritis	0.000248	0.00302	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000247	0.00733	CbGpPWpGaD
Chloroquine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000247	0.003	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000242	0.00717	CbGpPWpGaD
Chloroquine—Convulsion—Prednisolone—psoriatic arthritis	0.000235	0.00287	CcSEcCtD
Chloroquine—Eosinophilia—Methotrexate—psoriatic arthritis	0.000234	0.00285	CcSEcCtD
Chloroquine—Alopecia—Dexamethasone—psoriatic arthritis	0.00023	0.0028	CcSEcCtD
Chloroquine—Alopecia—Betamethasone—psoriatic arthritis	0.00023	0.0028	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—HLA-DRB1—psoriatic arthritis	0.000228	0.00678	CbGpPWpGaD
Chloroquine—Angioedema—Triamcinolone—psoriatic arthritis	0.000228	0.00278	CcSEcCtD
Chloroquine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000228	0.00277	CcSEcCtD
Chloroquine—Hallucination—Prednisone—psoriatic arthritis	0.000226	0.00275	CcSEcCtD
Chloroquine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000225	0.00274	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000222	0.0027	CcSEcCtD
Chloroquine—Neutropenia—Methotrexate—psoriatic arthritis	0.000221	0.0027	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000219	0.00649	CbGpPWpGaD
Chloroquine—Convulsion—Triamcinolone—psoriatic arthritis	0.000216	0.00264	CcSEcCtD
Chloroquine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000216	0.00263	CcSEcCtD
Chloroquine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000216	0.00263	CcSEcCtD
Chloroquine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000211	0.00257	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000209	0.00255	CcSEcCtD
Chloroquine—Angioedema—Dexamethasone—psoriatic arthritis	0.000207	0.00252	CcSEcCtD
Chloroquine—Angioedema—Betamethasone—psoriatic arthritis	0.000207	0.00252	CcSEcCtD
Chloroquine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000205	0.0025	CcSEcCtD
Chloroquine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000204	0.00248	CcSEcCtD
Chloroquine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000203	0.00248	CcSEcCtD
Chloroquine—Insomnia—Prednisolone—psoriatic arthritis	0.000201	0.00244	CcSEcCtD
Chloroquine—Alopecia—Prednisone—psoriatic arthritis	0.0002	0.00244	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.0002	0.00594	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.000199	0.0059	CbGpPWpGaD
Chloroquine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000197	0.0024	CcSEcCtD
Chloroquine—Convulsion—Dexamethasone—psoriatic arthritis	0.000196	0.00239	CcSEcCtD
Chloroquine—Convulsion—Betamethasone—psoriatic arthritis	0.000196	0.00239	CcSEcCtD
Chloroquine—Anxiety—Betamethasone—psoriatic arthritis	0.000192	0.00234	CcSEcCtD
Chloroquine—Anxiety—Dexamethasone—psoriatic arthritis	0.000192	0.00234	CcSEcCtD
Chloroquine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00019	0.00231	CcSEcCtD
Chloroquine—Hepatitis—Methotrexate—psoriatic arthritis	0.00019	0.00231	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	0.000189	0.0056	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—NOD2—psoriatic arthritis	0.000188	0.00557	CbGpPWpGaD
Chloroquine—Vision blurred—Prednisone—psoriatic arthritis	0.000186	0.00227	CcSEcCtD
Chloroquine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000185	0.00225	CcSEcCtD
Chloroquine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000185	0.00225	CcSEcCtD
Chloroquine—Insomnia—Triamcinolone—psoriatic arthritis	0.000184	0.00225	CcSEcCtD
Chloroquine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000184	0.00224	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	0.000183	0.00543	CbGpPWpGaD
Chloroquine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000183	0.00222	CcSEcCtD
Chloroquine—Visual impairment—Methotrexate—psoriatic arthritis	0.000183	0.00222	CcSEcCtD
Chloroquine—Agitation—Prednisone—psoriatic arthritis	0.000181	0.00221	CcSEcCtD
Chloroquine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000181	0.00221	CcSEcCtD
Chloroquine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000181	0.00221	CcSEcCtD
Chloroquine—Angioedema—Prednisone—psoriatic arthritis	0.00018	0.0022	CcSEcCtD
Chloroquine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000179	0.00218	CcSEcCtD
Chloroquine—Tinnitus—Methotrexate—psoriatic arthritis	0.000177	0.00215	CcSEcCtD
Chloroquine—Anorexia—Dexamethasone—psoriatic arthritis	0.000176	0.00215	CcSEcCtD
Chloroquine—Anorexia—Betamethasone—psoriatic arthritis	0.000176	0.00215	CcSEcCtD
Chloroquine—Urticaria—Prednisolone—psoriatic arthritis	0.000176	0.00214	CcSEcCtD
Chloroquine—Hypotension—Dexamethasone—psoriatic arthritis	0.000173	0.0021	CcSEcCtD
Chloroquine—Hypotension—Betamethasone—psoriatic arthritis	0.000173	0.0021	CcSEcCtD
Chloroquine—Convulsion—Prednisone—psoriatic arthritis	0.000171	0.00208	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	0.00017	0.00505	CbGpPWpGaD
Chloroquine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000168	0.00205	CcSEcCtD
Chloroquine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000168	0.00204	CcSEcCtD
Chloroquine—Anxiety—Prednisone—psoriatic arthritis	0.000167	0.00204	CcSEcCtD
Chloroquine—Alopecia—Methotrexate—psoriatic arthritis	0.000167	0.00204	CcSEcCtD
Chloroquine—Insomnia—Betamethasone—psoriatic arthritis	0.000167	0.00204	CcSEcCtD
Chloroquine—Insomnia—Dexamethasone—psoriatic arthritis	0.000167	0.00204	CcSEcCtD
Chloroquine—Urticaria—Triamcinolone—psoriatic arthritis	0.000162	0.00197	CcSEcCtD
Chloroquine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000162	0.00197	CcSEcCtD
Chloroquine—TLR9—Immune System—REL—psoriatic arthritis	0.000162	0.0048	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000161	0.00196	CcSEcCtD
Chloroquine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000161	0.00196	CcSEcCtD
Chloroquine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000161	0.00196	CcSEcCtD
Chloroquine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000161	0.00196	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00016	0.00194	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00016	0.00194	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—NOS2—psoriatic arthritis	0.000158	0.00468	CbGpPWpGaD
Chloroquine—Vision blurred—Methotrexate—psoriatic arthritis	0.000155	0.00189	CcSEcCtD
Chloroquine—Anorexia—Prednisone—psoriatic arthritis	0.000154	0.00187	CcSEcCtD
Chloroquine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000152	0.00186	CcSEcCtD
Chloroquine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000152	0.00186	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—HLA-B—psoriatic arthritis	0.000151	0.00448	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-C—psoriatic arthritis	0.000149	0.00441	CbGpPWpGaD
Chloroquine—Urticaria—Betamethasone—psoriatic arthritis	0.000147	0.00179	CcSEcCtD
Chloroquine—Urticaria—Dexamethasone—psoriatic arthritis	0.000147	0.00179	CcSEcCtD
Chloroquine—Asthenia—Triamcinolone—psoriatic arthritis	0.000146	0.00178	CcSEcCtD
Chloroquine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000146	0.00178	CcSEcCtD
Chloroquine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000146	0.00178	CcSEcCtD
Chloroquine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000146	0.00178	CcSEcCtD
Chloroquine—Insomnia—Prednisone—psoriatic arthritis	0.000146	0.00177	CcSEcCtD
Chloroquine—Pruritus—Triamcinolone—psoriatic arthritis	0.000144	0.00176	CcSEcCtD
Chloroquine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000144	0.00175	CcSEcCtD
Chloroquine—Convulsion—Methotrexate—psoriatic arthritis	0.000143	0.00174	CcSEcCtD
Chloroquine—Decreased appetite—Prednisone—psoriatic arthritis	0.00014	0.00171	CcSEcCtD
Chloroquine—Rash—Prednisolone—psoriatic arthritis	0.00014	0.0017	CcSEcCtD
Chloroquine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000139	0.00169	CcSEcCtD
Chloroquine—Headache—Prednisolone—psoriatic arthritis	0.000139	0.00169	CcSEcCtD
Chloroquine—Confusional state—Methotrexate—psoriatic arthritis	0.000136	0.00165	CcSEcCtD
Chloroquine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000135	0.00164	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—CRP—psoriatic arthritis	0.000133	0.00396	CbGpPWpGaD
Chloroquine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000133	0.00162	CcSEcCtD
Chloroquine—Asthenia—Dexamethasone—psoriatic arthritis	0.000133	0.00162	CcSEcCtD
Chloroquine—Asthenia—Betamethasone—psoriatic arthritis	0.000133	0.00162	CcSEcCtD
Chloroquine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000132	0.00161	CcSEcCtD
Chloroquine—Nausea—Prednisolone—psoriatic arthritis	0.000132	0.0016	CcSEcCtD
Chloroquine—Pruritus—Dexamethasone—psoriatic arthritis	0.000131	0.00159	CcSEcCtD
Chloroquine—Pruritus—Betamethasone—psoriatic arthritis	0.000131	0.00159	CcSEcCtD
Chloroquine—Vomiting—Triamcinolone—psoriatic arthritis	0.00013	0.00158	CcSEcCtD
Chloroquine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000129	0.00157	CcSEcCtD
Chloroquine—Rash—Triamcinolone—psoriatic arthritis	0.000129	0.00157	CcSEcCtD
Chloroquine—Anorexia—Methotrexate—psoriatic arthritis	0.000128	0.00156	CcSEcCtD
Chloroquine—Rash—Methylprednisolone—psoriatic arthritis	0.000128	0.00156	CcSEcCtD
Chloroquine—Urticaria—Prednisone—psoriatic arthritis	0.000128	0.00156	CcSEcCtD
Chloroquine—Headache—Triamcinolone—psoriatic arthritis	0.000128	0.00156	CcSEcCtD
Chloroquine—Headache—Methylprednisolone—psoriatic arthritis	0.000127	0.00155	CcSEcCtD
Chloroquine—Abdominal pain—Prednisone—psoriatic arthritis	0.000127	0.00155	CcSEcCtD
Chloroquine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000127	0.00154	CcSEcCtD
Chloroquine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000127	0.00154	CcSEcCtD
Chloroquine—Hypotension—Methotrexate—psoriatic arthritis	0.000126	0.00153	CcSEcCtD
Chloroquine—Insomnia—Methotrexate—psoriatic arthritis	0.000122	0.00148	CcSEcCtD
Chloroquine—Nausea—Triamcinolone—psoriatic arthritis	0.000121	0.00147	CcSEcCtD
Chloroquine—Nausea—Methylprednisolone—psoriatic arthritis	0.000121	0.00147	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	0.000118	0.00351	CbGpPWpGaD
Chloroquine—Vomiting—Dexamethasone—psoriatic arthritis	0.000118	0.00143	CcSEcCtD
Chloroquine—Vomiting—Betamethasone—psoriatic arthritis	0.000118	0.00143	CcSEcCtD
Chloroquine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000117	0.00143	CcSEcCtD
Chloroquine—Rash—Dexamethasone—psoriatic arthritis	0.000117	0.00142	CcSEcCtD
Chloroquine—Rash—Betamethasone—psoriatic arthritis	0.000117	0.00142	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000116	0.00142	CcSEcCtD
Chloroquine—Headache—Betamethasone—psoriatic arthritis	0.000116	0.00141	CcSEcCtD
Chloroquine—Headache—Dexamethasone—psoriatic arthritis	0.000116	0.00141	CcSEcCtD
Chloroquine—Asthenia—Prednisone—psoriatic arthritis	0.000116	0.00141	CcSEcCtD
Chloroquine—Pruritus—Prednisone—psoriatic arthritis	0.000114	0.00139	CcSEcCtD
Chloroquine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000111	0.00135	CcSEcCtD
Chloroquine—Diarrhoea—Prednisone—psoriatic arthritis	0.00011	0.00134	CcSEcCtD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.00011	0.00327	CbGpPWpGaD
Chloroquine—Nausea—Dexamethasone—psoriatic arthritis	0.00011	0.00134	CcSEcCtD
Chloroquine—Nausea—Betamethasone—psoriatic arthritis	0.00011	0.00134	CcSEcCtD
Chloroquine—TLR9—Immune System—NOD2—psoriatic arthritis	0.000109	0.00325	CbGpPWpGaD
Chloroquine—Urticaria—Methotrexate—psoriatic arthritis	0.000107	0.0013	CcSEcCtD
Chloroquine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000106	0.0013	CcSEcCtD
Chloroquine—Vomiting—Prednisone—psoriatic arthritis	0.000102	0.00125	CcSEcCtD
Chloroquine—Rash—Prednisone—psoriatic arthritis	0.000102	0.00124	CcSEcCtD
Chloroquine—Headache—Prednisone—psoriatic arthritis	0.000101	0.00123	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	0.0001	0.00297	CbGpPWpGaD
Chloroquine—Asthenia—Methotrexate—psoriatic arthritis	9.66e-05	0.00118	CcSEcCtD
Chloroquine—Nausea—Prednisone—psoriatic arthritis	9.57e-05	0.00117	CcSEcCtD
Chloroquine—Pruritus—Methotrexate—psoriatic arthritis	9.53e-05	0.00116	CcSEcCtD
Chloroquine—Diarrhoea—Methotrexate—psoriatic arthritis	9.21e-05	0.00112	CcSEcCtD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	9.13e-05	0.00271	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	9.13e-05	0.00271	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-B—psoriatic arthritis	8.79e-05	0.00261	CbGpPWpGaD
Chloroquine—Vomiting—Methotrexate—psoriatic arthritis	8.56e-05	0.00104	CcSEcCtD
Chloroquine—Rash—Methotrexate—psoriatic arthritis	8.49e-05	0.00103	CcSEcCtD
Chloroquine—Headache—Methotrexate—psoriatic arthritis	8.43e-05	0.00103	CcSEcCtD
Chloroquine—Nausea—Methotrexate—psoriatic arthritis	8e-05	0.000974	CcSEcCtD
Chloroquine—TLR9—Immune System—CRP—psoriatic arthritis	7.77e-05	0.00231	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-DRB1—psoriatic arthritis	7.44e-05	0.00221	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	4.73e-05	0.0014	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	2.33e-05	0.000693	CbGpPWpGaD
